| UniProt ID | ELF2_HUMAN | |
|---|---|---|
| UniProt AC | Q15723 | |
| Protein Name | ETS-related transcription factor Elf-2 | |
| Gene Name | ELF2 {ECO:0000312|EMBL:AAF67195.1} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 593 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Isoform 1 transcriptionally activates the LYN and BLK promoters and acts synergistically with RUNX1 to transactivate the BLK promoter.; Isoform 2 may function in repression of RUNX1-mediated transactivation.. | |
| Protein Sequence | MTSAVVDSGGTILELSSNGVENQEESEKVSEYPAVIVEPVPSARLEQGYAAQVLVYDDETYMMQDVAEEQEVETENVETVEASVHSSNAHCTDKTIEAAEALLHMESPTCLRDSRSPVEVFVPPCVSTPEFIHAAMRPDVITETVVEVSTEESEPMDTSPIPTSPDSHEPMKKKKVGRKPKTQQSPISNGSPELGIKKKPREGKGNTTYLWEFLLDLLQDKNTCPRYIKWTQREKGIFKLVDSKAVSKLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKDMPKNIVVIDDDKSETCNEDLAGTTDEKSLERVSLSAESLLKAASSVRSGKNSSPINCSRAEKGVARVVNITSPGHDASSRSPTTTASVSATAAPRTVRVAMQVPVVMTSLGQKISTVAVQSVNAGAPLITSTSPTTATSPKVVIQTIPTVMPASTENGDKITMQPAKIITIPATQLAQCQLQTKSNLTGSGSINIVGTPLAVRALTPVSIAHGTPVMRLSMPTQQASGQTPPRVISAVIKGPEVKSEAVAKKQEHDVKTLQLVEEKPADGNKTVTHVVVVSAPSAIALPVTMKTEGLVTCEK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 (in isoform 2) | Phosphorylation | - | 20.12 | 26714015 | |
| 3 (in isoform 3) | Phosphorylation | - | 20.12 | 26714015 | |
| 3 (in isoform 4) | Phosphorylation | - | 20.12 | 26714015 | |
| 4 (in isoform 2) | Phosphorylation | - | 9.00 | 26714015 | |
| 4 (in isoform 3) | Phosphorylation | - | 9.00 | 26714015 | |
| 4 (in isoform 4) | Phosphorylation | - | 9.00 | 26714015 | |
| 8 | Phosphorylation | MTSAVVDSGGTILEL CCEEEECCCCEEEEE | 27.75 | 27251275 | |
| 11 | Phosphorylation | AVVDSGGTILELSSN EEECCCCEEEEECCC | 26.39 | 27251275 | |
| 16 | Phosphorylation | GGTILELSSNGVENQ CCEEEEECCCCCCCH | 16.63 | 27251275 | |
| 17 | Phosphorylation | GTILELSSNGVENQE CEEEEECCCCCCCHH | 50.67 | 27251275 | |
| 47 (in isoform 2) | Phosphorylation | - | 55.58 | 25849741 | |
| 54 (in isoform 2) | Phosphorylation | - | 1.64 | 28111955 | |
| 56 (in isoform 2) | Phosphorylation | - | 17.32 | 24719451 | |
| 95 | Phosphorylation | NAHCTDKTIEAAEAL CCCCCHHHHHHHHHH | 27.19 | 23312004 | |
| 107 | Phosphorylation | EALLHMESPTCLRDS HHHHCCCCCCCCCCC | 20.24 | 30266825 | |
| 107 (in isoform 1) | Phosphorylation | - | 20.24 | 25849741 | |
| 109 | Phosphorylation | LLHMESPTCLRDSRS HHCCCCCCCCCCCCC | 33.19 | 30266825 | |
| 114 | Phosphorylation | SPTCLRDSRSPVEVF CCCCCCCCCCCCEEE | 28.37 | 28102081 | |
| 114 (in isoform 1) | Phosphorylation | - | 28.37 | 28111955 | |
| 116 | Phosphorylation | TCLRDSRSPVEVFVP CCCCCCCCCCEEECC | 36.93 | 24275569 | |
| 116 (in isoform 1) | Phosphorylation | - | 36.93 | 24719451 | |
| 125 (in isoform 2) | Ubiquitination | - | 2.86 | 21890473 | |
| 137 (in isoform 3) | Ubiquitination | - | 21.38 | 21890473 | |
| 142 | Phosphorylation | AMRPDVITETVVEVS HHCCCEEEEEEEEEE | 26.00 | - | |
| 150 (in isoform 4) | Ubiquitination | - | 49.28 | 21890473 | |
| 153 | Phosphorylation | VEVSTEESEPMDTSP EEEECCCCCCCCCCC | 40.54 | - | |
| 158 | Phosphorylation | EESEPMDTSPIPTSP CCCCCCCCCCCCCCC | 30.10 | - | |
| 163 | Phosphorylation | MDTSPIPTSPDSHEP CCCCCCCCCCCCCCC | 54.32 | 24275569 | |
| 167 (in isoform 2) | Ubiquitination | - | 32.89 | 21890473 | |
| 170 | Phosphorylation | TSPDSHEPMKKKKVG CCCCCCCCCCCCCCC | 34.17 | 19651622 | |
| 173 | Phosphorylation | DSHEPMKKKKVGRKP CCCCCCCCCCCCCCC | 52.12 | 19651622 | |
| 176 | Phosphorylation | EPMKKKKVGRKPKTQ CCCCCCCCCCCCCCC | 14.23 | 19651622 | |
| 179 | Phosphorylation | KKKKVGRKPKTQQSP CCCCCCCCCCCCCCC | 44.96 | 19413330 | |
| 179 (in isoform 3) | Ubiquitination | - | 44.96 | 21890473 | |
| 182 | Phosphorylation | KVGRKPKTQQSPISN CCCCCCCCCCCCCCC | 40.13 | 23927012 | |
| 185 | Phosphorylation | RKPKTQQSPISNGSP CCCCCCCCCCCCCCC | 17.87 | 30266825 | |
| 185 (in isoform 1) | Ubiquitination | - | 17.87 | 21890473 | |
| 188 | Phosphorylation | KTQQSPISNGSPELG CCCCCCCCCCCCCCC | 38.22 | 30266825 | |
| 191 | Phosphorylation | QSPISNGSPELGIKK CCCCCCCCCCCCCCC | 21.32 | 23927012 | |
| 197 | Ubiquitination | GSPELGIKKKPREGK CCCCCCCCCCCCCCC | 53.60 | - | |
| 197 (in isoform 5) | Ubiquitination | - | 53.60 | 21890473 | |
| 198 | Ubiquitination | SPELGIKKKPREGKG CCCCCCCCCCCCCCC | 67.12 | - | |
| 227 (in isoform 1) | Ubiquitination | - | 7.62 | 21890473 | |
| 229 | Ubiquitination | NTCPRYIKWTQREKG CCCHHHCCCHHHCCC | 34.94 | - | |
| 239 | Ubiquitination | QREKGIFKLVDSKAV HHCCCEEEEECHHHH | 45.76 | - | |
| 239 (in isoform 5) | Ubiquitination | - | 45.76 | 21890473 | |
| 243 | Ubiquitination | GIFKLVDSKAVSKLW CEEEEECHHHHHHHH | 18.29 | - | |
| 248 | Ubiquitination | VDSKAVSKLWGKHKN ECHHHHHHHHHCCCC | 41.48 | - | |
| 256 | Ubiquitination | LWGKHKNKPDMNYET HHHCCCCCCCCCHHH | 47.39 | - | |
| 261 | Phosphorylation | KNKPDMNYETMGRAL CCCCCCCHHHHHHHH | 13.21 | - | |
| 269 | Methylation | ETMGRALRYYYQRGI HHHHHHHHHHHHCCC | 19.20 | - | |
| 270 | Phosphorylation | TMGRALRYYYQRGIL HHHHHHHHHHHCCCC | 13.84 | 28270605 | |
| 271 | Phosphorylation | MGRALRYYYQRGILA HHHHHHHHHHCCCCC | 6.16 | 28270605 | |
| 272 | Phosphorylation | GRALRYYYQRGILAK HHHHHHHHHCCCCCE | 5.25 | 28270605 | |
| 279 | Sumoylation | YQRGILAKVEGQRLV HHCCCCCEEECEEEE | 37.06 | - | |
| 279 | Ubiquitination | YQRGILAKVEGQRLV HHCCCCCEEECEEEE | 37.06 | - | |
| 287 | Phosphorylation | VEGQRLVYQFKDMPK EECEEEEEEECCCCC | 16.90 | - | |
| 290 | Ubiquitination | QRLVYQFKDMPKNIV EEEEEEECCCCCCEE | 37.28 | - | |
| 294 | Ubiquitination | YQFKDMPKNIVVIDD EEECCCCCCEEEECC | 53.31 | - | |
| 304 | Phosphorylation | VVIDDDKSETCNEDL EEECCCCCCCCCCCC | 45.17 | 25849741 | |
| 306 | Phosphorylation | IDDDKSETCNEDLAG ECCCCCCCCCCCCCC | 27.93 | 28348404 | |
| 314 | Phosphorylation | CNEDLAGTTDEKSLE CCCCCCCCCCHHHHH | 26.01 | 18669648 | |
| 315 | Phosphorylation | NEDLAGTTDEKSLER CCCCCCCCCHHHHHH | 41.04 | 23312004 | |
| 318 | Ubiquitination | LAGTTDEKSLERVSL CCCCCCHHHHHHHCC | 64.25 | - | |
| 319 | Phosphorylation | AGTTDEKSLERVSLS CCCCCHHHHHHHCCC | 33.15 | 23312004 | |
| 324 | Phosphorylation | EKSLERVSLSAESLL HHHHHHHCCCHHHHH | 23.87 | 30108239 | |
| 326 | Phosphorylation | SLERVSLSAESLLKA HHHHHCCCHHHHHHH | 23.60 | 23917254 | |
| 329 | Phosphorylation | RVSLSAESLLKAASS HHCCCHHHHHHHHHH | 38.42 | 30108239 | |
| 332 | Ubiquitination | LSAESLLKAASSVRS CCHHHHHHHHHHHHC | 47.39 | - | |
| 341 | Acetylation | ASSVRSGKNSSPINC HHHHHCCCCCCCCCC | 55.70 | 26051181 | |
| 343 | Phosphorylation | SVRSGKNSSPINCSR HHHCCCCCCCCCCCH | 40.76 | 27794612 | |
| 344 | Phosphorylation | VRSGKNSSPINCSRA HHCCCCCCCCCCCHH | 38.91 | 25159151 | |
| 351 | Phosphorylation | SPINCSRAEKGVARV CCCCCCHHHHCEEEE | 13.42 | 18669648 | |
| 360 | Phosphorylation | KGVARVVNITSPGHD HCEEEEEECCCCCCC | 29.03 | 18669648 | |
| 362 | Ubiquitination | VARVVNITSPGHDAS EEEEEECCCCCCCCC | 24.54 | - | |
| 362 | Phosphorylation | VARVVNITSPGHDAS EEEEEECCCCCCCCC | 24.54 | 21712546 | |
| 363 | Phosphorylation | ARVVNITSPGHDASS EEEEECCCCCCCCCC | 25.70 | 25159151 | |
| 369 | Phosphorylation | TSPGHDASSRSPTTT CCCCCCCCCCCCCCE | 32.13 | 23403867 | |
| 370 | O-linked_Glycosylation | SPGHDASSRSPTTTA CCCCCCCCCCCCCEE | 38.20 | 30059200 | |
| 370 | Phosphorylation | SPGHDASSRSPTTTA CCCCCCCCCCCCCEE | 38.20 | 21712546 | |
| 372 | O-linked_Glycosylation | GHDASSRSPTTTASV CCCCCCCCCCCEEEE | 28.66 | 30059200 | |
| 372 | Phosphorylation | GHDASSRSPTTTASV CCCCCCCCCCCEEEE | 28.66 | 30266825 | |
| 374 | O-linked_Glycosylation | DASSRSPTTTASVSA CCCCCCCCCEEEEEC | 37.72 | 30059200 | |
| 374 | Phosphorylation | DASSRSPTTTASVSA CCCCCCCCCEEEEEC | 37.72 | 30266825 | |
| 375 | O-linked_Glycosylation | ASSRSPTTTASVSAT CCCCCCCCEEEEECC | 24.61 | 30059200 | |
| 375 | Phosphorylation | ASSRSPTTTASVSAT CCCCCCCCEEEEECC | 24.61 | 30266825 | |
| 376 | O-linked_Glycosylation | SSRSPTTTASVSATA CCCCCCCEEEEECCC | 21.29 | 30059200 | |
| 376 | Phosphorylation | SSRSPTTTASVSATA CCCCCCCEEEEECCC | 21.29 | 30266825 | |
| 378 | O-linked_Glycosylation | RSPTTTASVSATAAP CCCCCEEEEECCCCC | 17.95 | 30059200 | |
| 378 | Phosphorylation | RSPTTTASVSATAAP CCCCCEEEEECCCCC | 17.95 | 30108239 | |
| 380 | O-linked_Glycosylation | PTTTASVSATAAPRT CCCEEEEECCCCCCC | 19.87 | 30059200 | |
| 380 | Phosphorylation | PTTTASVSATAAPRT CCCEEEEECCCCCCC | 19.87 | 30108239 | |
| 382 | O-linked_Glycosylation | TTASVSATAAPRTVR CEEEEECCCCCCCEE | 18.82 | 30059200 | |
| 382 | Phosphorylation | TTASVSATAAPRTVR CEEEEECCCCCCCEE | 18.82 | 30108239 | |
| 400 | O-linked_Glycosylation | QVPVVMTSLGQKIST ECCEEEECCCCCEEE | 16.65 | 30059200 | |
| 406 | O-linked_Glycosylation | TSLGQKISTVAVQSV ECCCCCEEEEEEEEC | 24.70 | 30059200 | |
| 410 | Phosphorylation | QKISTVAVQSVNAGA CCEEEEEEEECCCCC | 3.66 | 20068231 | |
| 412 | Phosphorylation | ISTVAVQSVNAGAPL EEEEEEEECCCCCCE | 15.67 | 20068231 | |
| 414 | Phosphorylation | TVAVQSVNAGAPLIT EEEEEECCCCCCEEE | 37.59 | 19413330 | |
| 415 | Phosphorylation | VAVQSVNAGAPLITS EEEEECCCCCCEEEE | 17.23 | 18669648 | |
| 417 | Phosphorylation | VQSVNAGAPLITSTS EEECCCCCCEEEECC | 8.04 | 19413330 | |
| 418 | Phosphorylation | QSVNAGAPLITSTSP EECCCCCCEEEECCC | 24.31 | 19413330 | |
| 421 | O-linked_Glycosylation | NAGAPLITSTSPTTA CCCCCEEEECCCCCC | 33.37 | 30059200 | |
| 421 | Phosphorylation | NAGAPLITSTSPTTA CCCCCEEEECCCCCC | 33.37 | 28450419 | |
| 422 | O-linked_Glycosylation | AGAPLITSTSPTTAT CCCCEEEECCCCCCC | 21.64 | 30059200 | |
| 422 | Phosphorylation | AGAPLITSTSPTTAT CCCCEEEECCCCCCC | 21.64 | 25159151 | |
| 423 | O-linked_Glycosylation | GAPLITSTSPTTATS CCCEEEECCCCCCCC | 30.03 | 30059200 | |
| 423 | Phosphorylation | GAPLITSTSPTTATS CCCEEEECCCCCCCC | 30.03 | 25159151 | |
| 424 | O-linked_Glycosylation | APLITSTSPTTATSP CCEEEECCCCCCCCC | 21.73 | 30059200 | |
| 424 | Phosphorylation | APLITSTSPTTATSP CCEEEECCCCCCCCC | 21.73 | 25159151 | |
| 426 | Phosphorylation | LITSTSPTTATSPKV EEEECCCCCCCCCCE | 28.91 | 19413330 | |
| 427 | O-linked_Glycosylation | ITSTSPTTATSPKVV EEECCCCCCCCCCEE | 31.18 | 30059200 | |
| 427 | Phosphorylation | ITSTSPTTATSPKVV EEECCCCCCCCCCEE | 31.18 | 28348404 | |
| 429 | Phosphorylation | STSPTTATSPKVVIQ ECCCCCCCCCCEEEE | 43.39 | 25159151 | |
| 430 | Phosphorylation | TSPTTATSPKVVIQT CCCCCCCCCCEEEEE | 21.91 | 25159151 | |
| 442 | Ubiquitination | IQTIPTVMPASTENG EEECCCCCCCCCCCC | 2.23 | - | |
| 451 | Ubiquitination | ASTENGDKITMQPAK CCCCCCCCCEECCCE | 41.28 | - | |
| 461 | Phosphorylation | MQPAKIITIPATQLA ECCCEEEEEEHHHHH | 25.12 | 19413330 | |
| 468 | Ubiquitination | TIPATQLAQCQLQTK EEEHHHHHHCCCCCC | 9.78 | - | |
| 479 | Phosphorylation | LQTKSNLTGSGSINI CCCCCCCCCCCCEEE | 33.29 | 22210691 | |
| 489 | Phosphorylation | GSINIVGTPLAVRAL CCEEECCCCEEEEEC | 12.30 | 25159151 | |
| 494 | Methylation | VGTPLAVRALTPVSI CCCCEEEEECCCEEE | 20.48 | 24129315 | |
| 497 | O-linked_Glycosylation | PLAVRALTPVSIAHG CEEEEECCCEEECCC | 22.21 | 30059200 | |
| 497 | Phosphorylation | PLAVRALTPVSIAHG CEEEEECCCEEECCC | 22.21 | 25159151 | |
| 500 | O-linked_Glycosylation | VRALTPVSIAHGTPV EEECCCEEECCCCCE | 18.43 | 30059200 | |
| 500 | Phosphorylation | VRALTPVSIAHGTPV EEECCCEEECCCCCE | 18.43 | 28450419 | |
| 505 | O-linked_Glycosylation | PVSIAHGTPVMRLSM CEEECCCCCEEEEEC | 11.66 | 30059200 | |
| 505 | Phosphorylation | PVSIAHGTPVMRLSM CEEECCCCCEEEEEC | 11.66 | 22199227 | |
| 509 | Methylation | AHGTPVMRLSMPTQQ CCCCCEEEEECCCCC | 24.68 | - | |
| 509 | Phosphorylation | AHGTPVMRLSMPTQQ CCCCCEEEEECCCCC | 24.68 | 19413330 | |
| 511 | Phosphorylation | GTPVMRLSMPTQQAS CCCEEEEECCCCCCC | 16.61 | 22199227 | |
| 514 | Phosphorylation | VMRLSMPTQQASGQT EEEEECCCCCCCCCC | 25.35 | 30576142 | |
| 518 | Phosphorylation | SMPTQQASGQTPPRV ECCCCCCCCCCCCCE | 27.39 | 30266825 | |
| 521 | Phosphorylation | TQQASGQTPPRVISA CCCCCCCCCCCEEEE | 38.49 | 30266825 | |
| 527 | Phosphorylation | QTPPRVISAVIKGPE CCCCCEEEEEEECHH | 17.39 | 27251275 | |
| 531 | Acetylation | RVISAVIKGPEVKSE CEEEEEEECHHHCCH | 62.91 | 25953088 | |
| 531 | Ubiquitination | RVISAVIKGPEVKSE CEEEEEEECHHHCCH | 62.91 | - | |
| 536 | Sumoylation | VIKGPEVKSEAVAKK EEECHHHCCHHHHHH | 40.70 | - | |
| 536 | Sumoylation | VIKGPEVKSEAVAKK EEECHHHCCHHHHHH | 40.70 | 25218447 | |
| 549 | Sumoylation | KKQEHDVKTLQLVEE HHCCCCCEEEEEEEE | 49.96 | - | |
| 557 | Ubiquitination | TLQLVEEKPADGNKT EEEEEEECCCCCCCE | 31.81 | - | |
| 564 | O-linked_Glycosylation | KPADGNKTVTHVVVV CCCCCCCEEEEEEEE | 34.34 | 30059200 | |
| 566 | O-linked_Glycosylation | ADGNKTVTHVVVVSA CCCCCEEEEEEEEEC | 17.74 | 30059200 | |
| 572 | O-linked_Glycosylation | VTHVVVVSAPSAIAL EEEEEEEECCCCEEC | 23.89 | 30059200 | |
| 575 | O-linked_Glycosylation | VVVVSAPSAIALPVT EEEEECCCCEECCEE | 31.83 | 30059200 | |
| 582 | O-linked_Glycosylation | SAIALPVTMKTEGLV CCEECCEEEECCCCE | 15.83 | 30059200 | |
| 582 | Phosphorylation | SAIALPVTMKTEGLV CCEECCEEEECCCCE | 15.83 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ELF2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ELF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ELF2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ZBT32_HUMAN | ZBTB32 | physical | 20211142 | |
| A4_HUMAN | APP | physical | 21832049 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-182; SER-185; SER-191;THR-426; THR-429; SER-430 AND THR-521, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363 AND SER-372, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-191, AND MASSSPECTROMETRY. | |